Giovannoni G, et al. Treatment outcomes of daclizumab in patients at high risk of transitioning to secondary progressive multiple sclerosis in DECIDE. EAN 2107, O2113.
Prix Galien voor Spinraza, FreeStyle Libre en Reinoud Gosens
nov 2018 | Multipele Sclerose, Neuro-musculair